With a heritage of almost 70 years in discovering and developing new therapeutic agents to protect and preserve vision, eye care professionals and patients rely on Allergan products to treat a variety of eye conditions. Our robust research and development investment upholds our unwavering commitment to advancing eye care treatments. Unfortunately , the prevalence of eye diseases is increasing as the population ages. Over the next decade, major progress will be made in treating such diseases and Allergan, an AbbVie company, expects to be at the forefront of these advances.
